David et al. found that the tumor tissues from mice treated with PLX3397/PTX enhanced anti-tumor immunity, blocked tumor-associated macrophage infiltration, and were beneficial to tumor inhibition mediated by CD8+ T cells (DeNardo et al., 2011). The gene discussed is CD8A; the disease is neoplasm.